Thus, the decreased expression of huMETCAM/MUC18 correlates with the emergence of three subtypes of NPC, suggesting that huMETCAM/MUC18 may function as a tumor suppressor in the development of NPC during the progression of the disease [11]. This evidence concerns the gene MCAM and neoplasm.